You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.
The findings underscore the value of carrying out large-scale human genetic analyses as part of drug target identification and validation efforts.
While new ways to carry out pool testing for SARS-CoV-2 abound, questions remain about sensitivity issues and the regulation of such tests.
The launch of the company's Prism system earlier this month should support the development of an accompanying menu of tests to serve diverse users.
Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed.
The researchers presented their findings during the European Society of Human Genetics meeting, which was webcast this week.
The Oxford, UK-based firm announced the closure of a seed financing round this week as well as plans to develop a methylation-based blood test for early-stage cancer detection.
The partners aim to identify signatures to predict the severity of disease in those infected and determine how patients will respond to therapies.
The UK Department of Health and Social Care has already ordered 10,000 RNA test cartridges from the company, which expects to obtain a CE-IVD mark for its test within weeks.
Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.